Cargando…
Tumor microenvironment-associated lactate metabolism regulates the prognosis and precise checkpoint immunotherapy outcomes of patients with lung adenocarcinoma
BACKGROUND: Despite the wide clinical application of checkpoint inhibitor immunotherapy in lung adenocarcinoma, its limited benefit to patients remains puzzling to researchers. One of the mechanisms of immunotherapy resistance may be the dysregulation of lactate metabolism in the immunosuppressive t...
Autores principales: | Qiu, Song, Wang, Ying, Rao, Hui, Que, Qiuyang, Wu, Yanyang, Zhu, Rui, Feng, Xiaofei, Chi, Jun, Lai, Weiling, Sun, Yihang, Xiao, Qi, Shi, Huaqiu, Xiang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677690/ https://www.ncbi.nlm.nih.gov/pubmed/36411477 http://dx.doi.org/10.1186/s40001-022-00895-6 |
Ejemplares similares
-
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
por: Zeng, Dongqiang, et al.
Publicado: (2021) -
Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Shang, Shipeng, et al.
Publicado: (2022) -
Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer
por: Xiang, Yi, et al.
Publicado: (2022) -
Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023) -
The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy
por: Tang, Yun-Qiang, et al.
Publicado: (2020)